Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study.

Trial Profile

Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Cetuximab; Gemcitabine
  • Indications Biliary cancer
  • Focus Therapeutic Use
  • Acronyms ECHO
  • Most Recent Events

    • 09 Feb 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
    • 09 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top